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Abstract 
Health care policy seeks to ensure that citizens are protected from the financial risk associated 
with needing health care. Yet rising health care costs in many countries are leading to a greater 
reliance on out-of-pocket (OOP) measures. This paper uses 2010 household survey data from 
seven countries to measure and compare the burden OOP expenses place on individuals.  It 
compares countries based on the extent to which citizens with health problems devote a large 
share of their income to OOP expenses. The paper finds that in all countries but France, and to a 
lesser extent Slovenia, citizens with health problems face considerably higher medical costs than 
do those without.  As many as one-quarter of less healthy citizens in the US, Poland, Russia and 
Israel devote a large share of their income to OOP expenses.  The paper also finds a strong cross-
national correlation between the degree to which citizens face high OOP expenses, and the 
disparities in OOP expenses between those with and without health problems.  The levels of high 
OOP spending uncovered, and their inequitable impact on those with health problems in the 
seven countries, underscore the potential for OOP measures to undermine core objectives of 
health care systems, including those of equitable financing, equal access, and improved health 
among the population.  
 







The central purpose of health insurance is to pool the risk of high medical expenses so 
that these costs are instead spread across the population.   Yet over the last decade, countries 
have responded to rising health care costs by introducing greater cost-sharing measures so that 
the users of health care face larger expenses [1-5].  This trend raises the question of how well the 
design of health insurance in different countries accomplishes the goal of protecting citizens 
from the risk of large out-of-pocket (OOP) expenses.  
Certainly, relying on the users of health care to pay some (or occasionally even all) of 
their medical expenses can be good policy:  It can help to reduce the risk of moral hazard 
associated with insurance by reducing the less valuable uses of health care dollars [6,7].  In many 
instances, paying out-of-pocket (OOP) can also be fairer than paying though insurance as some 
health expenses reflect individuals’ preferences and income rather than medical necessity.    
But high OOP requirements can also undermine the fundamental goals of a nation’s 
health care system.  They can render the financing of medical care less equitable, as paying for 
health care out-of-pocket is generally the most regressive way to finance it [8,9].  When they are 
high, OOP requirements can also cause some to meet their health care needs only by sacrificing 
other essential purchases, such as for food, shelter and education.  Meeting these expenses also 
requires some to assume debt or liquidate assets intended for other purposes [10,11].  Not 
surprisingly, such ways of coping with high OOP requirements have been found to be more 
common among those in poor health and/or with chronic health problems [11,12].   
Most importantly, paying for health care out-of-pocket can deter individuals from 
medical care, pharmaceutical products, and other needed medical goods [11, 13-19].  The poor 
[14,19], elderly [19], and those with health problems [11, 20]  have been shown to be the most 
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sensitive to OOP requirements.  Moreover, not only can cost-sharing practices lead to a reduction 
in the use of medical services and a weaker adherence to medication therapies, they have also 
been shown to result in poorer health outcomes [13,19,21].  For these reasons, researchers and 
policy makers are paying increased attention to the amount citizens pay out-of-pocket to receive 
medical services and products [1, 3-5, 22-25].  
Yet very few studies investigate citizens’ exposure to high OOP spending within a cross-
national context.  Making cross-country comparisons based on single country studies is generally 
difficult, as these comparisons are compromised by differences in the data sets, or in how out-of-
pocket expenditures or income are defined and measured.  However, cross-national comparisons 
are of increasing relevance, as countries face the similar public health challenges of reducing 
health care costs, distributing these costs fairly, and assuring equitable access to health care—all 
while meeting the growing medical needs of an aging population.  How OOP expenditures 
feature into meeting or detracting from these goals is of growing concern in nearly all developed 
countries.  Improved cross-national comparisons can aid in understanding the link between the 
scope and design of health insurance and the distribution of OOP expenditures.  Such 
comparisons should also be included in comparative evaluations of how well countries meet their 
common health care objectives. 
This paper contributes to a cross-national comparison of the burden created by out-of-
pocket expenses by using nationally-representative household survey data from seven developed 
countries, where the data have been harmonized for the purpose of allowing cross-national 
comparisons.  The paper matches groups of individuals across the seven countries based on their 
common responses to questions regarding their health, and compares these groups with respect to 
the percentage of household income spent on OOP expenditures.  It then assesses the seven 
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countries based on the frequency of high OOP expenses among those with similar health 
indicators, and the amount spent on OOP expenses at the tail end of the spending distribution 
(both defined below). The paper provides some of the best evidence to date on variation among 
countries in the degree to which those most in need of health care face large financial barriers to 
gaining access to it. 
 
Methods 
This paper measures the frequency with which citizens providing the same response to 
questions regarding their health (described below) in seven countries face high OOP expenses, 
where “high” is measured uniformly across the seven countries.  It makes this comparison by 
calculating citizens’ OOP medical spending relative to income in a single year, and then 
determining the percentage of individuals in each country with OOP expenses exceeding a 
threshold percentage of their income.  It compares citizens across countries based on their 
common responses to one of three different measures of their health status, as detailed below.  It 
also investigates differences within the seven countries in the share of income spent on OOP 
costs by those with health problems spending at the 90th spending/income percentile of their 
cohort, thus comparing the impact of OOP requirements for those spending at the upper tail of 
each country’s spending distribution.  
For both of these estimations, the paper uses nationally-representative household survey 
data from seven developed countries made available through the Luxembourg Income Study 
(LIS).  LIS produces harmonized versions of nations’ household surveys to facilitate cross-
national research on social policy.   
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To choose the nations to compare in this study, we selected all LIS datasets that are no 
more than ten years old, that generate OOP spending levels roughly consistent with those 
published by the OECD, that employ standard definitions of OOP spending, and that have 
income levels close to those in Europe.  This selection process left three countries in Europe 
(France, Poland, and Slovenia), three in Asia and the Middle East (Russia, Israel and Japan), and 
one in North America (the United States).  For all seven countries except Japan (2008), the paper 
uses household survey data for the calendar year 2010.  All data sets contain information on 
nationally-representative households, and provide weights for making national-level estimations.  
An online Appendix A provides information and notes on each data set used.  Table 1 provides 
summary data for each country on household income and OOP expenses; as shown there, the 
number of observations in each country ranges from 3,900 in Slovenia to over 200,000 in the 
United States.  All calculations presented here are based on weighted individual-level 
observations.  
 
Table 1 here 
 
As an indication of the representativeness of the countries chosen for this study, Table 2 
compares a large number of developed countries based on two measures of their OOP spending 
reported by the OECD:  the percentage of all health spending made up by OOP spending 
(column 1), and per-capita OOP expenditures (column 2).  As shown, the countries in this study 
are somewhat representative of the range and distribution of OOP spending found in this larger 
sample of countries, both in terms of the relative (column 1) as well as absolute (column 2) size 
of OOP expenditures.  Using relative indicators, France is at the low end of the distribution 
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(OOP expenditures comprise 7.5% of all health expenditures), Israel is average (18.2 %), and 
Russia is at the high end (36.4%).  In absolute terms, France, Slovenia and Poland (around $300 
per capita) spend significantly below the average, Israel and Russia (around $500) are fairly 
typical, and the US ($988) is at the high end of the spending spectrum. 
 
Table 2 here 
 
Table 3 provides further detail on differences among the seven countries in this study.  
The first three columns present the relative importance in each nation of the three primary 
funding sources for the country’s health care system:  general tax revenue, social insurance 
payments, and private payments (the combination of private insurance and OOP expenses).  As 
shown, France, Japan, Poland and Slovenia rely primarily on social insurance payments, whereas 
Russia and the US rely to a greater degree on private funding sources.  Israel relies on a mixture 
of all three sources.  Prior research has found that general taxes tends to result in the least 
regressive way to finance health care, while private financing tends to be the most [8].  Where 
available, the last column of Table 3 identifies the policies used in countries to limit OOP 
expenses.  As shown, the mix of policies is typical of what is found in other countries:  special 
protection is offered to certain populations (typically the ill, children elderly, and/or the poor), 
and in some instances, countries have established income-based limits on OOP expenditures.  
 




 Out-of-pocket Spending.  Out-of-pocket spending is defined by LIS as total household 
expenditures on medical products, appliances and equipment, outpatient services and hospital 
services, and excludes health insurance premiums.  The countries in this study adhere relatively 
closely to this definition, which comes from Code 06 of the United Nation’s Classification of 
Individual Consumption According to Purpose.  To verify the quality of LIS’s OOP spending 
data, we compare OOP spending in each of the seven surveys with amounts published by the 
OECD (compare Table 1 with Table 2).  All seven country estimates from LIS fall within 72% to 
96% of the OECD’s estimates.  That per-capita OOP estimates from LIS are below the OECD’s 
is expected:  household surveys generally exclude the institutionalized population (e.g., those in 
long-term care facilities) and individuals who died earlier in the year.  For both of these 
populations, OOP spending can be high.  Recent evidence also raises questions about the 
reliability of the OECD’s estimates [26].  
High Medical Expenses.  This paper follows the common practice of labeling 
households as having high OOP spending when the amount they spend exceeds a certain 
percentage of income [1, 5, 9, 22, 27].  Especially in developed countries, income is the most 
commonly used measure of a household’s ability to pay.  In this paper all members of a 
household are designated as having high OOP spending when the amount spent exceeds 10% of 
their income, or 5% if the household is in poverty, both of which are defined below.  This 
measurement reflects the most common practice of using a 10% threshold, but often lowering it 
if the household is poor [1, 28, 29].  It should be noted, however, that this measure of “high 
spending” is conservative insofar as it entails an arbitrary division between the “poor” and the 
“non-poor.”   It also does not capture as high-spenders those with low costs due to their 
underutilization of medical care or medication, which could be significant [30].  
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Income.  LIS data provide excellent information on household income which is 
consistently measured across different countries.  The paper defines income as disposable 
income, which is superior to other measures since it takes into account the value of government 
taxes paid and social transfers received.  This is especially important for those with health 
problems, since disposable income includes any benefits received from disability, social 
insurance, social assistance, and public pension policies.  As with OOP spending, income is 
measured at the household level.   
Poverty.  Individuals are identified as in poverty when the equivalized form of household 
disposable income (disposable income divided by the square root of household size) is below a 
poverty threshold.  For this threshold, this paper employs the European Commission’s definition 
of poverty, which is income below 60% of the median.  Those individuals with (equivalized) 
disposable income below 60% of the nation’s equivalized median value are thus labeled as being 
poor.  Because all individuals in the same household have the same equivalized income, they all 
have the same poverty status.  
  Health Status.  The seven household surveys each capture respondent’s and their family 
members’ health status through responses to one or two of three different health-related 
questions.  The answers to two of these three questions are coded as 1 if the individual answers 
“yes” to the specific health problem, and 0 otherwise.  For one such question, a “yes” response 
indicates the individual has a permanent health condition (either physical or mental) that limits 
basic activity; all countries except for Japan and France provide information for this “Disability” 
question.  The percent of yes (disabled) responses differs across countries, ranging from 1% in 
Slovenia to 10% in the US (see online Appendix B).  Much of this variation likely reflects the 
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specific way the Disability question is worded in the different countries (see online Appendix A 
for detail). 
A second health indicator question asks if a household member has a chronic illness or 
disease.  France and Japan were the only countries to provide responses to this “Illness” question 
(in France’s case, it captures whether or not an individual was hospitalized during the previous 
year, see Online Appendix A), with Japan providing it for the household head and spouse only 
(see online Appendix A).  Japan’s “Illness” rate (25%) is slightly higher than France’s (21%), 
although as noted, the question was asked differently in the two countries.   
Japan, Russia, Slovenia and the United States all provide information on a third measure 
of individuals’ health: respondents ranked each individual household member’s health from 1 
(excellent) to 5 (bad).  For the purposes of this study, this variable is used to create a third health 
indicator variable, where individuals are deemed in “Poor Health” if they report either being in 
poor or bad health (a ranking of 4 or 5), or they are deemed not in poor health (i.e., they report a 
health ranking of 1, 2 or 3).  In Slovenia, this variable is available only for household heads, and 
in Japan it is only provided for household heads and spouses.  The percentage of the population 
reporting to be in poor health ranges from 12% to 14%, suggesting a great deal of similarity 
across countries in how respondents categorize household members’ health.  For this reason, the 
Poor Health indicator is likely the most reliable of the three used in this study for matching 
individuals across the seven countries based on their health. .Detail on the distribution of the 





How does the degree of financial protection against the risk of large OOP expenses 
compare across the seven countries?  How does this protection differ for those with health 
problems compared with the rest of the population?  Finally, how much do those with health 
problems pay in high OOP expenses at the tail end of the spending distribution in the different 
countries?  
To answer the first question, Table 4 column 1 presents country-level estimates of the 
percentage of citizens with high OOP expenses in each of the seven countries, where “high” is as 
defined earlier.  As shown, more than 10% of individuals in the US, Poland, Israel and Russia 
lived in households with high OOP spending, and only in France did less than 5% of individuals 
have high OOP expenses.  
 
Table 4 here 
  
 To compare the incidence of high OOP spending by citizens’ health status in the seven 
countries, Table 4 presents estimates of the percentage of individuals with large OOP expenses 
by health status based on each of the three different indicators of health problems previously 
discussed (“Disability”, “Illness”, and “Poor Health”).  Table 4 also presents the amount of OOP 
expenses as a share of income by health status, for those spending at the 90th percentile.  For 
instance, among citizens reporting to be disabled, those in Slovenia  spending at the 90th 
percentile spent 9% of their income on OOP expenses, whereas the same group at the same point 
of the spending distribution in Israel spent 18% of their income on OOP expenses.  Together 
these two statistics provide comparative indicators of the extent to which health care costs within 
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a county fall disproportionately on those who need it more:  the first measures the prevalence of 
high OOP costs, and the second measures how high these costs can reach.  
 As Table 3 shows, differences in the incidence of high OOP spending between the 
disabled and non-disabled population exceeds ten percentage points in the United States, Poland, 
Israel and Russia, while differences in Slovenia (four percentage points) are the smallest.  
Comparing rates between those with and without a chronic illness in France and Japan reveals 
small difference in the prevalence of high OOP expenses between these two groups, perhaps 
reflecting the weaker nature of this indicator of individuals’ health status. 
 The last two columns in Table 4 present rates of high OOP spending among those 
categorized in poor health versus not in poor health.  By this indicator, we see that those in poor 
health in Japan, Russia and the US are at significantly higher risks of large OOP expenses 
compared with those not in poor health.  The gap between the two populations is largest in 
Russia, where an estimated 33% of those in poor health had high OOP expenses in 2010, 
compared with 14% among those not in poor health.  By this Poor Health indicator, Slovenia 
offers the best financial protection of the four countries, as only 15% of Slovenians reporting 
poor health had high OOP expenses, and only 9% of Slovenians not in poor health had high 
expenses.  
With the exception of the Illness variable—which is very likely a weak indicator of 
health status (see online Appendix A)--the results reveal that those with health problems are 
exposed to a significantly higher risk of large OOP spending than are those without them:  in all 
countries, the risk roughly doubles for this population compared with those without health 
problems.  But in France especially, and to a lesser extent Slovenia, “greater risk” is relative to a 
population provided significant protection from high financial costs.  In absolute terms, the 
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overall estimates show that a quarter or more of citizens with health problems in Poland, Russia, 
the US and Israel had high OOP expenses in 2010, with slightly better outcomes in Japan.   
Comparing spending levels at the 90th percentile for each group in the seven countries 
similarly reveals large difference between them:  typically those with health problems spend 
about 75 percent more than do those without health problems.  For instance, a disabled person at 
the 90 percentile of spending among the disabled in Poland devoted 16% of her income to OOP 
expenses, whereas a non-disabled at this point of the non-disabled spending distribution in 
Poland spent only 9% of income on OOP expenses.   
Figure 1 graphically represents the cross-country relationship between the frequency of 
high OOP expenses in each country (the X axis) and the difference in this frequency between 
those with and without indicators of a health problem (Y axis).  For instance, as shown in Table 
4 column 1, an estimated 15% of the population in Israel faces high OOP costs (X axis), whereas 
there is an estimated 11 percentage point difference is high costs (Y axis) between those who are 
disabled and those who are not (26% versus 15%).   This shows a clear pattern where countries 
in which large OOP expenses are more common (X axis) also have a larger gap between the 
frequency of high OOP spending between citizens with and without health problems.  In other 
words, where a country’s health policies expose citizens to a higher overall risk of large OOP 
expenses, this translates into a greater disparity between those with and without health problems 
in the financial burden health care places on them.  This association makes intuitive sense:  if 
health policy within a country exposes a larger percentage of citizens to substantial costs from 
using medical services, then we would expect that additional exposure to fall disproportionately 




Figure 1 here 
 
The sample of counties in this study, then, reveals a strong pattern where exposure to a 
higher risk of incurring large OOP expenses places a more uneven financial burden on those with 
health problems versus those without.  But not only do we see this association, but we also see 
that a higher exposure to large OOP expenses is associated with more extreme levels of OOP 
requirements at the household level.  This is shown in Figure 2, where the X axis once again 
measures the incidence of high OOP spending in each country, but the Y axis now captures the 
amount spent on OOP expenses as a share of income at the 90th percentile of spending among 
those with indicators of health problems (see Table 4).  As Figure 2 shows, nations that expose 
citizens to a higher risk of large OOP expenses (X axis), also expose their citizens with health 
problems to especially high levels of spending requirements.  For instance in Russia (the 
northeast corner of Figure 2), 17% of its population had high OOP expenses in 2010, and among 
those reporting to be disabled, the 90th percentile of OOP/income spending reached 20%.  The 
distinct pattern depicted in Figure 2 suggests a separate manifestation of the problem associated 
with high exposure to OOP expenses:   it tends to also expose citizens in poor health to 
extremely large levels of out-of-pocket medical expenses. 
 
Figure 2 here 
 
In our sample of countries, then, the degree of exposure to large OOP expenses is closely 
associated with the extent to which those with health problems disproportionately face high OOP 
expenses, and the chance that these costs will reach extremely high levels.  This association 
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becomes even more concerning when one examines who it is that tends to have health problems.  
Table 5 displays the age and income profile of those reporting health problems in the seven 
countries.  On average, those with indicators of health problems were about twice as likely to be 
poor, and several times more likely to be 65 years or older.  As shown elsewhere, the risk of 
having large OOP expenses is especially pronounced among the poor and elderly, where it is not 
uncommon for one-quarter or more of poor citizens to devote at least 5% of their income to out-
of-pocket expenses [31].  Thus, in the sample countries here, exposure to high OOP expenses 
disproportionately shifts health care financing to those with health problems, thereby placing a 
greater financial burden  on the poor and elderly-- the precise citizens least able to bear these 
expenses, and the ones most likely to respond to them by reducing their health care consumption 
[11, 14, 19, 20]. 
 
Table 5 here 
 
Discussion  
 This study presents comparable cross-national indicators of the incidence of high out-of-
pocket medical expenses among those with similar indicators of their health status.  Within each 
of the seven countries, the design and scope of insurance leaves the unhealthy more exposed to 
high OOP costs than it does the healthy.  Looking across countries, the absolute magnitude of 
this risk varies considerably.  Health policy in France provides the best financial protection 
against the costs associated with adverse health outcomes, with Slovenia a distant second.  
Numerous measures in France help account for citizens’ minimal exposure to high OOP 
expenses.  For one, most French citizens purchase secondary private insurance to cover the at 
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times extensive cost-sharing requirements of public insurance.  And those below a particular 
income threshold are provided supplemental public insurance at no cost.   Many vulnerable 
citizens (including those with particular health problems) are also exempt from all OOP 
requirements [32].  These measures explain why overall, OOP expenditures account for only 
7.5% of France’s health care expenditures.  Indeed, the results here show a .78 correlation 
between a country’s reliance on OOP expenditures (column 1 of Table 2) and the percent of 
citizens with high OOP expenses (Column 1 Table 4), and a stronger .83 correlation between a 
reliance on OOP and the amount spent by those at the 90th spending percentile (Column 1 Table 
4).  
By contrast, the US, Poland, Russia and Israel stand out for the significant exposure their 
citizens have to high OOP expenses, an outcome that the paper shows in these countries 
disproportionately shifts the financing of health care costs to low-income households, citizens in 
poor health, and the elderly.  Moreover, it also is associated with these individuals being more 
exposed to the risk of extremely high OOP expenses.  Overall in our sample, nations relying on 
private spending sources do tend to place a more inequitable financial burden on those with 
health problems; however, this association is also almost completely attributable to the OOP 
component of private expenditures rather than a reliance on private insurance.    
There are a couple of important limitations to this study.  First, it estimates the risk of 
high OOP spending by actual spending patterns.  As such it does not count those for whom OOP 
spending falls below the threshold of “high” only because they forgo needed medical services 
and products rather than pay its cost.  This omission may lead to significantly underestimating 
the risk of incurring high medically-related costs [30], especially in countries with high levels of 
OOP requirements [33].  Second, the comparisons are based on self-reported measures of health, 
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and the definitions of “Illness” and “Disability” used in each of the countries often differed.   For 
this reason, the comparisons across countries for these variables should be considered suggestive 
rather than exact, and likely underestimate true disparities within countries. Third, no single 
measure of citizens’ health status is available for all seven countries. 
Finally, in measuring the frequency and magnitude of large OOP spending, the paper 
does not address what the right amount or the appropriate conditions are for individuals to pay 
out-of-pocket, as opposed to pre-paying collectively via taxes or premiums.  Paying out-of-
pocket may advance the objective of constraining the burden medical care places on public 
budgets and private premiums, and moderating citizens’ incentive to overconsume health care 
[6,7].  It may also reflect a preferred reduction in the cost of premiums in exchange for higher 
OOP expenses. Yet the levels of high OOP spending uncovered in most of the countries here, 
and their disparate effect on individuals with health problems, the poor and the elderly, 
underscores its widespread potential to undermine core objectives of health care systems, 
including those of equitable financing, equal access, and improved health among the population.   
 
Conclusions 
Despite universal insurance in six of the seven countries in this study, and the widespread 
existence of policies that supposedly limit citizens’ financial exposure to high OOP expenses [4, 
34, 35, see Table 3], the paper finds that large levels of OOP spending are common in all but 
France.  It is perhaps noteworthy that according to one attempt to classify nations’ health care 
systems, France, Poland, Japan and Israel all have common institutional arrangements for 
regulating, financing, and providing health care within their nation [36].  Yet according to this 
paper’s findings, these similarities do not translate into similar levels of financial protection.  
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Exactly how countries do and do not accomplish the level of financial protection each provides 
deserves further detailed analyses, although as previously discussed, health policy in France is 
specifically designed to restrict the potential for OOP expenses at the household level to climb.  
Indeed, the findings here indicate the centrality of this feature of health care policy to achieve 
equitable financing of and equal access to health care. 
In addition to more closely investigating how and why OOP expenses in countries can 
mount (or not), another implication of this study is the increasing importance of monitoring the 
incidence of high OOP spending within countries.  That it is a common occurrence in many 
countries reveals an aspect of nations’ health care system that is currently not very visible.  
Collecting and publicizing this data is especially important given that health care costs are rising, 
as have out-of-pocket costs in most countries.    
A challenge for public health is making sure that OOP requirements are consistent with 
the goals of financing equity, equal access, and improved medical outcomes.  For countries to 
attain financial protection on par with that achieved in France, they will need to enact more 
comprehensive income-based limits on OOP spending than currently exist in most countries.  
However, the magnitude of financial risk revealed here indicates that in order to reduce health 
care costs, countries should seek alternative methods to the one examined here:  shifting the cost 
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HH Disposable Income Out of Pocket Expenses 
 
    Median Per Average Median 
 
No. Obs (1) Average Equivalized Capita HH HH 
       France 40,837 $44,513 $23,510 $235 $602 $282 
Israel 20,203 $39,350 $16,192 $372 $1,275 $508 
Japan 5,318  /  5,332 $51,727 $22,824 $419 $1,537 $744 
Poland 107,147 $23,914 $10,932 $285 $821 $464 
Russia 15,027  /  15,037 $24,220 $10,490 $387 $1,130 $359 




203,799 $63,837 $29,990 $708 $2,024 $850 
       (1) Where there are two numbers, the first is for observations with the Disabled 
variable, and the second is for observations using the Health Status variable.  See 
online Appendix A for more detail on observations.Calculations are based on the 
number of observations indicated. 
Notes:  HH=Household.  All amounts expressed in 2010 US$ (except Japan, 2008) 
using the OECD's Purchasing Power Parity index for private consumption, available at 
http://stats.oecd.org/Index.aspx?datasetcode=SNA_TABLE4# 




Table 2:  Out-of-Pocket Medical Expenses, Per Capita and as a Share of Total Health 












  USA  12.0 $988 
France  7.5 $300 
Israel  18.2 $501 
Japan  14.4 $436 
Poland  22.1 $317 
Slovenia  12.2 $300 
Russia  36.4 $472 
Switzerland  25.1 $1,253 
Australia  19.3 $730 
Belgium  20.8 $836 
Canada  14.4 $637 
Czech Rep  14.9 $286 
Denmark  13.2 $598 
Estonia  18.6 $242 
Finland  19.6 $645 
Germany  13.1 $581 
Hungary  26.3 $447 
Iceland  18.2 $619 
Ireland  18.2 $690 
Italy  17.5 $553 
Korea  34.0 $704 
Luxembourg  9.6 $448 
New Zealand  10.5 $318 
Portugal  25.8 $721 
Slovak Rep  21.7 $442 
Spain  19.8 $597 
Sweden  16.3 $613 
UK  8.8 $282 
OECD AVG  19.0 
  Source: OECD Health Statistics 2014, available at 
http://stats.oecd.org/Index.aspx?DataSetCode=SHA.  Per-capita 
expressed in 2010 purchasing power parity dollars (PPP$), except 






Table 3:  Source of Health Care Financing and Limits on OOP, by Country (2010) 
 Financing of Health Care (% of total)  
 Public Private  
 General Soc. Insurance   Limits on OOP 
     
France 2.8 74.2 22.0 Caps on 
deductibles, some 
exemptions for low 
income, ill, disabled 
and chldren 
     
Israel 17.0 46.5 35.3 N/A 
      
Japan 9.4 72.0 18.1 Coinsurance 
reduced after 
monthly cap 
reached.  Reduced 
cost sharing for low 
income, children, 
young children, and 
elderly. 
      




      
Russia 29.5 23.8 46.7 N/A 
      
Slovenia 4.4 68.9 26.7 N/A 
      
US 24.6 23.8 51.6 Little cost sharing 
for low income 
individuals on 
Medicaid 
     





Table 4:  Out of Pocket (OOP) Expenses for Total Population and By Health Status:  
Percent With Large OOP Expenses, and OOP as a Share of Income At 90th Spending 
Percentile 
 
Total Disabled Illness Poor Health 
 
Population Yes No Yes No Yes No 
France 
          % High OOP 3% n/a  n/a      4%   3% n/a n/a 
   90th % OOP/Inc 4% n/a  n/a  5% 3% n/a  n/a  
        Israel 
           % High OOP 15% 26% 15% n/a  n/a  n/a  n/a  
   90th % OOP/Inc 11% 18% 10% n/a  n/a  n/a  n/a  
        Japan 
           % High OOP 9% n/a  n/a  13% 9% 21% 8% 
   90th % OOP/Inc 7% n/a  n/a  9% 7% 15% 7% 
        Poland 
           % High OOP 13% 25% 11% n/a  n/a  n/a  n/a  
   90th % OOP/Inc 10% 16% 9% n/a  n/a  n/a  n/a  
        Russia 
           % High OOP 17% 29% 15% n/a  n/a  33% 14% 
   90th % OOP/Inc 12% 20% 12% n/a  n/a  21% 11% 
        Slovenia 
          % High OOP 7% 11% 7% n/a  n/a  15% 9% 
   90th % OOP/Inc 7% 9% 7% n/a  n/a  11% 7% 
        United States 
       % High OOP 13% 25% 11% n/a  n/a  25% 10% 
   90th % OOP/Inc 9% 17% 9% n/a  n/a  17% 8% 
Note:  Total population based on entire dataset.  All estimations based on weighted 
observations for calendar year 2010, except Japan (2008).  High OOP defined as OOP 
expenditures exceeding 10% of disposable income, or 5% of household income is below 60% 
of the median. 
Source:  Authors calculations based on LIS data (www.lisdatacenter.org). 




Table 5:  Composition of Subpopulations Based on Health Status:  Percent that are Poor and Elderly 
 
 
-------------Percent in Poverty by Health Status------- --------Percent Elderly by Health Status-------- 
 
Disabled Illness Poor Health 
 
Disabled Illness Poor Health 
 
Yes No Yes No Yes No 
 
Yes No Yes No Yes No 
              France n/a n/a 13% 16% n/a n/a 
 
n/a n/a 18% 16% n/a n/a 
              Israel 28% 28% n/a n/a n/a n/a 
 
10% 10% n/a n/a n/a n/a 
              Japan n/a n/a 19% 16% 25% 16% 
 
n/a n/a 20% 23% 41% 20% 
              Poland 22% 15% n/a n/a n/a n/a 
 
29% 11% n/a n/a n/a n/a 
              Russia 16% 21% n/a n/a 22% 21% 
 
51% 8% n/a n/a 50% 7% 
              Slovenia 24% 16% n/a n/a 45% 19% 
 
49% 16% n/a n/a 53% 21% 
              US 43% 20% n/a n/a 40% 22% 
 
35% 14% n/a n/a 34% 10% 
              Unwgt. Avg 27% 20% 16% 16% 33% 19% 
 
35% 12% 19% 20% 44% 14% 
Source:  Authors calculations based on LIS data (www.lisdatacenter.org).  Elderly defined as 65 years and older.  Poor defined as 
individuals with equivalized household disposable income below 60% of national median.  All data for calendar year 2010, except 
Japan (2008). 
